Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will LYB disclose European divestiture proceeds of $500M or more when the transaction closes in Q2 2026?
Current Prediction
Why This Question Matters
Tests the liquidity and capital-discipline storyline. Stress Scanner's coverage math and Roadkill Radar's orderly-recovery path both assume $500-800M in European divestiture proceeds. Proceeds at or above $500M validate the orderly-simplification thesis and extend balance-sheet optionality through the trough. Proceeds below $500M or a failed transaction signal distressed pricing on unprofitable assets and tighten the coverage math for the dividend/capex/Saudi-JV triangle.
Prediction Distribution
Individual Predictions(9 runs)
Committee's $500-800M range is presented as the assumption, implying some signaling basis. $500M is the lower bound of the range. Given (a) assets are loss-making at trough (Q4 -$61M EBITDA), (b) trough-pricing dynamics, (c) working-capital/environmental adjustments typically reduce reported figures, the expected-value is likely near the midpoint ($650M) with wide dispersion. Probability P(proceeds ≥ $500M) assuming symmetric distribution around $650M with sigma ~$200M is ~0.77; adjust down for distressed-pricing risk and ambiguous disclosure. Settle 0.55.
Chemical asset sales at trough often produce below-range proceeds as buyers demand discount. Private equity appetite for European chemical assets has been limited through 2024-2025. Strategic buyer pool narrow (competitor consolidation limited). The $500M threshold is the LOW end of the committee's cited range. If the transaction comes in at $500-800M, this resolves YES; only if it slips below $500M (distress) or the transaction is restructured/delayed does it resolve NO. Moderate uncertainty on close-date disclosure timing. Settle 0.52.
Management has cited Q2 2026 close with confidence; binding agreement already in place. Committee flagged 'portfolio simplification on track' with operational execution credibility. The $500-800M range is specific enough to suggest management has internal visibility. Some risk of delay but low risk of outright termination. Probability of close AND proceeds ≥$500M ~55-60%. Settle 0.58.
$500M threshold sits at the low boundary of committee's range. If distribution of outcomes is roughly uniform across $500-800M with 20% left-tail below $500M, probability YES ~0.70. However, discounting for close-timing risk and disclosure ambiguity, 0.50-0.55.
Committee range is $500-800M which straddles the threshold. Base case P(proceeds >=$500M | close on schedule) ~0.75-0.80. Adjusted for timing risk (~15% slip to Q3) ~0.60-0.65. Further adjusted for reporting ambiguity 0.55.
Balance committee range support (favorable) against trough-pricing on loss-making assets (unfavorable) and disclosure/timing risks. Central 0.50.
Committee range $500-800M; binding agreement; $500M threshold likely met but with close-timing risk. 0.55.
Moderate confidence; 50-55% reflects uncertainty on pricing and reporting.
Base case around midpoint of range; threshold at low end gives YES bias. 0.55.
Resolution Criteria
Resolves YES if LYB discloses, in an 8-K, press release, or Q2 2026 10-Q (filed by 2026-08-15), closing-date transaction proceeds or consideration of $500M or more (gross cash received, before working-capital adjustments). Resolves NO if disclosed proceeds are below $500M, if the transaction is terminated, delayed beyond Q3 2026, or if LYB discloses that proceeds will not be separately quantified (e.g., wrapped in a larger portfolio transaction).
Resolution Source
LYB 8-K closing announcement, Q2 2026 earnings release, or Q2 2026 10-Q
Source Trigger
European divestiture Q2 2026 closing — proceeds $500-800M range underpins Stress Scanner liquidity and Roadkill Radar recovery path
Full multi-lens equity analysis